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Edited by Takashi GojoboriAbstract ICAM-3 is a DC-SIGN ligand that is constitutively
expressed on resting leukocytes, and is thus an important mole-
cule for the ﬁrst immune response. But, ICAM-3 has not been iso-
lated form rodents. Thus, we compare the ICAM gene clusters in
human, dog, mouse, and rat. ICAM-1, -4, -5 and -3 are located
close to one another on the same chromosome and show genomic
synteny in human and dog. Almost the same ICAM gene clusters
were found in rodent genome, but only the ICAM-3 was not pres-
ent. A phylogenetic tree plotting the cDNAs of human, dog,
mouse, rat, and bovine suggested that ICAM-3 was made from
a duplication of ICAM-1. Thus, ICAM-3 arose from ICAM-1
in the mammalian evolution, but was lost in the rodents genome.
Our study suggests the diﬀerent immune response in the rodents
in comparison with other mammals.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Approximately 3.5–5.0% of the human genome consists of
highly conserved segmental duplicated regions [1]. These dupli-
cated regions that include entire genes, allow gene diversiﬁcation
and/or the creation of novel functional roles for existing genes
through selective constraints on one or more gene copies [2,3].
The ICAMs are type I membrane glycoproteins that are
members of the Ig superfamily [4]. In mammals, ﬁve ICAMs,
named ICAM-1 to -5, have been found [5–9]. Except for
ICAM-5, all the ICAMs function in the immune system [4].
ICAM-5 is speciﬁcally expressed in neuronal cells of the telen-
cephalon [10], but its function is still unclear.
ICAM-1 is expressed at low levels in resting leucocytes and
at almost undetectable levels on the vascular endothelium and
other cells [11]. However, ICAM-1 is rapidly upregulated by
inﬂammatory cytokines such as interferon-a, interleukin 1-b,
and tumor necrosis factor-a on many cell types, including leu-
kocytes, endothelium, keratinocytes, epithelial cells, and ﬁbro-
blasts [12]. These expression proﬁles indicate that ICAM-1
functions as a rapid-response molecule, present at low levels
in resting states, but able to be induced rapidly in appropriate
circumstances. In contrast, ICAM-3 is expressed at very high
levels on all resting leukocytes; its expression is restricted to*Fax: +81 6 6977 1922.
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seen for other ICAMs. Moreover, the upregulation of ICAM-3
expression is induced only on leukocytes [7].
Both ICAM-1 and -3 bind integrin LFA1 [5,13], which is ex-
pressed at the surface of leukocytes. However, given their dif-
ferent expression proﬁles, these ICAMs must have very
diﬀerent functions. Thus, ICAM-3 is thought to be a key li-
gand for leukocyte LFA1 in initiating immune responses.
ICAM-1s function could be initiated later, when the immune
response is actively in progress.
For the ﬁrst immune response, contact between dendritic cells
(DC) and resting T-cells is essential. DCs are professional anti-
gen-presenting cells that eﬃciently capture antigens to form an
MHC-peptide complex [14–16]. How the initial contact between
DCs and T cells, which is necessary for T-cell activation, is
established and regulated has been largely unknown. The aﬃn-
ity of LFA1, which is expressed onDCs, for ICAM-3, even after
integrin activation [17,18], is rather low [19,20], given that anti-
LFA1 antibodies partially inhibit interactions betweenDCs and
resting T-cells [21,22]. In 2000, a novel ICAM-3-binding C-type
lectin named DC-SIGN, which is exclusively expressed by DCs,
was shown to mediate strong adhesion between DCs and the
ICAM-3 on resting T cells, and to be essential for the induction
of T-cell proliferation [23]. Thus, ICAM-3 has a very important
role in the primary immune systems.
Except for ICAM-2 [24], all the ICAMs are clustered within
an 80-kb region on human chromosome 19p13.2 [25–27]. We
compared the genomic region containing the ICAMs in human,
dog, mouse, and rat. Our investigation found there was no
ICAM-3 or ICAM-3-like sequence in mouse and rat. In con-
trast, human and dog had ICAM-3. Genomic PCRs revealed
that all primates tested, from newworld monkeys to the human,
had ICAM-3. Bovine ICAM-3 has already been isolated [28].
Recent phylogenies of mammals place rodents and primates
in the same clade exclusive of other mammals [29]. Thus, the
ICAM-3 must have been duplicated from ICAM-1, but lost
in the rodent lineages in the mammalian evolution.2. Materials and methods
2.1. Sequence sources
The sequences of the human, dog, mouse, and rat ICAM genomic
loci were taken from the public draft assemblies available at the UCSC
genome browser (http://genome.ucsc.edu/) released May 2004
(human), July 2004 (dog), May 2004 (mouse), and June 2003 (rat).
The following coordinates were used to obtain the human, dog, mouse,
and rat sequences for Fig. 1: human chr19, 10231715-10322209; dog
chr20, 53642218-53695917; mouse chr9, 21558757-21670259; rat
chr8, 20031628-20128878.blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representatations of the human (A), dog (B), mouse (C), and rat (D) ICAM gene clusters. Exons are shown as vertical black boxes.
Bars connecting the genes of the four mammals indicate the corresponding genes and gene clusters. Arrows over the exons indicate their orientations
on the chromosomes. In A and B, ICAM-3 is indicated in red.
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Evolutionary tree: The cDNA sequences that encode the protein re-
gions of all the ICAMs in the ﬁve mammals investigated were aligned
by a multi-sequence Clustal X analysis (http://workshop.molecularev-
olution.org/software/clustalx/). Evolutionary trees were obtained by
NJ analysis (1000 bootstraps). Comparisons of genomic regions: The
genomic regions of ICAM-1 and -3, including the 10-kb upstream re-
gions, were compared by the PipMaker program (http://pip-
maker.bx.psu.edu/pipmaker/). The repeats were unmasked with the
Repeat Masker program (http://www.repeatmasker.org/).
2.3. Genomic PCR
The human genomic DNAs were purchased from CLONTECH;
chimpanzee, gorilla, and orangutan genomic DNAs were kindly pro-
vided by Drs. A. Fuijiyama and N. Sakaki (RIKEN); gibbon, Patas
monkey, African green monkey, owl monkey, Pinche and ring-tailed
lemur genomic DNAs were kindly provided by Dr. T. Ishida
(University of Tokyo). The forward primer was designed for a
consensus sequence in exon 1 of human RAVER1 and mouse and
rat N24Rik (RAV-EX1: 5 0-AGGCGTTTCCGGATCTCTTC-3 0).
The reverse primers were designed for the consensus sequences in exon
1 of human and dog ICAM-3 (I3-EX1-1, 5 0-TGGGC GTGGTGAC-
TATGC-3 0; I3-EX1-2, 5 0-CTGCTGGAGGGTCC-3 0). For the bovine
ICAM-3, the reverse primer was designed for exon 1 using the se-
quence in the public database (NM174349; I3-EX1-3, 5 0-CAC-
CCAGGGTCTACTGGACT-3 0). The ampliﬁcation was performed
for 30 cycles; each cycle consisted of 20 s of denaturation at 98 C
and 10 min of annealing and elongation at 65 C. LA-Taq polymerase
(TAKARA) was used.
2.4. DNA sequencing of PCR products
The ampliﬁed PCR fragments were isolated from agarose gels using
a QIAEXII gel extraction kit (QIAGEN), and direct sequencing using
an ABI-3100 Genetic Analyzer (Applied Biosystems/Hitachi) was per-
formed for the extracted DNAs.3. Results
3.1. Comparison of the organization of human, dog, mouse, and
rat ICAM gene clusters
To elucidate the evolutionary origins of ICAM gene clusters
in mammals, we retrieved the genomic sequences of thehuman, dog, mouse, and rat ICAM gene clusters using the
UCSC Genome Browser Home (http://genome.ucsc.edu/). In
all four mammals, ICAM-1, -4, and -5 were located close to
one another on the chromosome and showed genomic synteny
(Fig. 1). These ICAMs were found between MRPL4 and tyro-
sine kinase 2 (TYK2). In all four mammals, RAVER1 (or
N24Rik, the rodent counterpart of human RAVER1) lay be-
tween ICAM-5 and TYK2. Moreover, in the human and the
dog we found an extra ICAM, ICAM-3 (Fig. 1A and B).
The ICAM-3s were located between RAVER1 and TYK2,
with the opposite orientation from ICAM-1, -4, and -5. In ro-
dents, not even relic sequences of ICAM-3 were found between
N24Rik and Tyk2 (Fig. 1C and D). Only ICAM-2 is located
on another chromosome (human, chromosome 17; dog, chro-
mosome 9; mouse, chromosome 11; and rat, chromosome 10),
where it lies between SCN4A and ERN1 (data not shown).
3.2. ICAM-3 in other mammals
Next, to elucidate whether ICAM-3 existed in other mam-
mals, we performed genomic PCR for primates, from new
world monkeys to humans, and for bovine ICAM-3. However
bovine ICAM-3 was already isolated [28], we performed the
genomic PCR for the bovine to verify that ICAM-3 and RA-
VER1 were linked in bovine genome as they are in other mam-
mals. The sense primer was located at the ﬁrst exon of
RAVER1 (Fig. 2A). The sequence of this primer was common
to the human, mouse, and rat. Because the sequences of
ICAM-3 are diversiﬁed in human and dog, we used three dif-
ferent reverse primers. Reverse primer 1 (ICAM-3-EX1-2) was
used for the anthropoids (from the gibbon to the human). Re-
verse primer 2 (ICAM-3-EX1-2) was used for the other mon-
keys (from the Ring-tailed lemur to the Patas monkey).
Reverse primer 3 (ICAM-3-EX1-3) was used for the bovine.
In all primates and bovine, discrete bands of approximately
5.5–7.0 kb were ampliﬁed, and terminal sequence analysis of
all the PCR products showed that they were all ICAM-3 and
RAVER1. The sequence of the ﬁrst exon and ﬁrst intron of
ICAM-3 of the Ring-tailed lemur and human have 92% simi-
Fig. 2. Genomic PCRs of the sequence between RAVER1, exon 1 and ICAM-3, exon 1 for 10 primates and a bovine. A schematic representation of
RAVER1 and ICAM-3 is shown in (A). The locations of the PCR primers are indicated above the exons. The 5.5–7.0-kb discrete bands (B) include
ICAM-3.
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genomic PCR for four laboratory mouse strains (DBA2
C3H, BALB/c, 129) and three wild-type mouse strains
(PGN2 (M. m. domesticus), BLG2 (M. m. musculus), and
HMI (M. m. castaneus)), and failed to obtain any PCR prod-
ucts (data not shown).
3.3. The origin of ICAM-3
Comparison of the deduced primary amino acid domain
structures of all human ICAMs showed that ICAM-1 and -3
have the same domain structures (Fig. 3A). The evolutionary
relationships among all the ICAMs for human, dog, bovine,
rat, and mouse is displayed in Fig. 3B. The phylogenetic tree
shows that the ICAM-3s branched oﬀ from the ICAM-1s. Be-
cause rat and mouse split from one another 12 million years
ago, and human and dog split approximately 65 million years
ago, the evolutionary distance between the mouse and rat is
much smaller than between human and dog. Compared with
the other Ig-CAMs (NCAM1-, NCAM-2, L1CAM and
MAG), the phylogenetic tree analysis shows that the ICAM
family has diversiﬁed (data not shown). Among the ICAMs,
the most closely related domain is the N-terminal one. There
is a gradient of homology, with decreasing similarity toward
the C-terminus. The LFA1-binding site has been mapped to
domain 1, the functions of other domains have not been eluci-
dated. The relative diversiﬁcation of the ICAMs compared
with the other Ig-CAMs may be a consequence of their bearing
nonfunctional domains. In contrast, the NCAMs, L1CAM,
and Mag bind homophilically, using all of their domains.
Interestingly, between ICAM-1 and -3, there is a higher-
than-expected homology between domain 2 and half of do-
main 3 [4]. So far, these domains have not been implicated
in LFA1 engagement, so it is intriguing that they should re-
main so well conserved in an apparently nonfunctional area.This similarity in nonfunctional domains strongly suggests that
ICAM-1 and -3 diversiﬁed recently, compared with the other
ICAMs.
3.4. Comparison of the ICAM-1 and -3 genomic regions
Because ICAM-1 and -3 have opposite genomic orienta-
tions, we compared the complementary genomic sequence of
ICAM-3 and the sense genomic sequence of ICAM-1 for hu-
man and dog. Both genomic sequences included approximately
10 kb of the 5 0 upstream regions, which extend to the 3 0 end of
TYK2.
We performed this comparison using PipMaker (http://pip-
maker.bx.psu.edu/pipmaker/) (Fig. 4). Exon 1 of both
ICAM-1 and -3 contained a translation initiation methionine
(ATG) followed by a putative signal peptide. Exons 2–6 en-
coded ﬁve individual Ig-like domains; these lie in the extracel-
lular region. Exon 7 contained both the trans-membrane and
cytoplasmic regions. In Fig. 4, A-1 shows human ICAM-1
vs. human ICAM-3; A-2 shows human ICAM-3 vs. human
ICAM-1; B-1 shows dog ICAM-1 vs. dog ICAM-3; B-2 shows
dog ICAM-3 vs. dog ICAM-1. Fig. 4A shows the highest sim-
ilarities of exons 3–6 between human ICAM-1 and –3, respec-
tively. Interestingly, human ICAM-1 and ICAM-3 share some
homology in non coding DNA upstream of exon 3–7 and in
the intron. Fig. 4B shows that exons 3–6 of the dog genomic
ICAM-1 and -3 sequences are also conserved. Moreover, the
relative positions of the ICAM-1 and -3 exons are similar.
Exons 3–7 are closely clustered within about 2 kb. In contrast,
exons 1 and 2 are located at a distance from the exon 3–7 clus-
ter. These similarities of genomic sequence and exon location
support the idea that a segmental duplication of ICAM-1 gen-
erated ICAM-3.
The regions surrounding the translation start site of human
and dog ICAM-1 have a high CG content, which is depicted by
Fig. 3. (A) Proposed model of the domain structures of human ICAMs 1–5. Individual Ig-like domains are numbered I-IX above. The extra- and
intracellular orientations are indicated by the NH2 and COOH at the ends of the protein chains. SS represents intrachain disulﬁde bonds. The two
short parallel lines denote the plasma membrane. ICAM-s 1and 3 are shaded. (B) Phylogenetic tree of human, dog, mouse, rat, and bovine ICAMs
(hICAM, human ICAM; dIICAM, dog ICAM; mICAM, mouse ICAM; rICAM, rat ICAM; bICAM, bovine ICAM). The phylogenetic tree was
created using cDNA sequences of protein-encoding regions. The numbers shown on the labeled branches are percentages that were calculated from
1000 bootstrap replicates. The scale bar equals a distance of 0.05.
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lost in human ICAM-3 and signiﬁcantly decreased in dog
ICAM-3. During the evolutionary period following the dupli-
cation of ICAM-1, the 5-methylated Cs were deaminated and
converted to T residues.4. Discussion
It has long been claimed that ICAM-3 and -1 are more clo-
sely related to each other than either is to other ICAMs [4]. Inthis report, we obtained strong evidence that ICAM-3 was gen-
erated by the segmental duplication of ICAM-1 in the mam-
malian evolution. In non-rodent animals, the segment
corresponding to the one between rodent Mrp14 and ICAM-
4 was duplicated and lies in the region between RAVER1
(the rodent N24Rik counterpart) and TYK2 in the reverse ori-
entation to the other ICAMs (Fig. 1). The comparative analy-
sis of the genomic region of ICAM-1 and -3 in human and dog
revealed a similar exon organization and high Pip ratio, includ-
ing in the intronic region. These similarities support the idea
that ICAM-3 originated as a duplication of ICAM-1.
Fig. 4. PipMaker plot of the regions surrounding the genomic regions of ICAM-s 1 and 3 with unmasked repeats. (A-1) Human ICAM-1 versus
human ICAM-3. (A-2) Human ICAM-3 versus human ICAM-1. (B-1) Dog ICAM-1 versus dog ICAM-3. (B-2) Dog ICAM-3 versus dog ICAM-1.
The corresponding regions of ICAM-s 1 and 3 are indicated by black bars.
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1). Thus, we could set up two hypotheses. First, the duplica-
tion that generated ICAM-3 from ICAM-1 was not ancestral
to the rodent lineage. Second, ICAM-3 was already duplicated
from ICAM-1 and present in the common ancestor of rodents
as well as other mammals, but only in the rodents, ICAM-3
was lost in their genome. Recently, mammalians phylogenies
have placed rodents and primates in the same clade exclusive
of other mammals [29]. In fact, based on rather extensive pub-
lished molecular data, rodent and primate are more closely
related to each other than either group is to carnivores (dog)
[29–33]. This strongly implies that ICAM-3 was already pres-
ent in common ancestor of mammalians. Therefore, more
likely explanation is that ICAM-3 was lost in the rodent line-
age by a deletion event. In support of a deletion being the
cause, evidence suggest that small-scale genomic DNA deletion
have played a signiﬁcant role in reducing the DNA content of
rodent genome [34] and this has resulted in loss of some gene
present in other mammals [35]. This is a simple and likely
explanation for the deletion of ICAM-3 in rodents.
ICAM-3 is constitutively expressed, mainly on resting leuko-
cytes, and binds to DCs, which present MHC-antigen peptides
through a C-type lectin named DC-SIGN [23]. Thus, ICAM-3
is a key molecule for the primary immune response. In this re-
port, we show that mouse and rat do not have ICAM-3. How-
ever, mouse DC-SIGN [36] has been found. The amino acid
sequence similarity between the carbohydrate recognition do-
main of human DC-SIGN and mouse DC-SIGN is 69% [36].
Thus, in rodents, instead of ICAM-3, ICAM-2 or some other
Ig family member that is expressed on resting leukocytes may
bind to DC-SIGN.Acknowledgments: This work was supported by Grants-in-aid from the
Ministry of Education, Science, Sports and Culture of Japan. We
thank Drs. A. Fujiyama, N. Sakaki (RIKEN), and Dr. T. Ishida (Uni-
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